SEC Form 4 · accession 0001571049-15-010330

PHIBRO ANIMAL HEALTH CORP · PAHC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Operating Officer · Director

Period of report

Dec 21, 2015

Accepted (ET)

Dec 23, 2015 · 9:00 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001069899

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Class A Common Stock	Dec 21, 2015	M	8,000	$11.83	A	8,000	D
Class A Common Stock^F2	Dec 21, 2015	S	8,000	$31.13	D	0	D
Class A Common Stock	Dec 22, 2015	M	1,071	$11.83	A	1,071	D
Class A Common Stock^F3	Dec 22, 2015	S	1,071	$32.02	D	0	D
Class A Common Stock	Dec 23, 2015	M	2,006	$11.83	A	2,006	D
Class A Common Stock^F4	Dec 23, 2015	S	2,006	$32.03	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option to purchase Class A Common Stock	$11.83	Dec 21, 2015	M	8,000	D	Apr 29, 2013	Feb 28, 2019	Class A Common Stock	8,000	112,050	D
Option to purchase Class A Common Stock	$11.83	Dec 22, 2015	M	1,071	D	Apr 29, 2013	Feb 28, 2019	Class A Common Stock	1,071	110,979	D
Option to purchase Class A Common Stock	$11.83	Dec 23, 2015	M	2,006	D	Apr 29, 2013	Feb 28, 2019	Class A Common Stock	2,006	108,973	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2015.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.60 to $31.62, inclusive.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.08, inclusive.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.17, inclusive.